DIALYSIS 332662
A dialysis facility in NY. It ran an operating loss of 2.3% in FY23 on $4.3M of operating revenue. Operating margin declined from 11.1% in FY20 to -2.3% in FY23.
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gatedRatios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.
| Line item | FY21 | FY22 | FY23 |
|---|---|---|---|
| Patient revenue | 7,329 | 5,633 | 4,292 |
| Total operating revenue | 7,329 | 5,633 | 4,292 |
| Total operating expenses | 5,851 | 4,959 | 4,390 |
| Operating income | 1,478 | 674 | (98) |
| Operating margin % | +20.2% | +12.0% | -2.3% |
| Other non-operating, net | 3 | 10 | (1) |
| Net income | 1,481 | 684 | (99) |
| Net income % | +20.2% | +12.1% | -2.3% |
Trajectory
State context
-2.3% operating margin in FY23.
Operating margin declined 14.2 points vs FY22 — the briefing traces why, line by line.
Reserve The Board Briefing →The Board Briefing
The record's final filed years, benchmarked against the peer pools of their own era and labeled so on every exhibit.